AgeX Therapeutics' Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001

Stock Information for Credit Suisse Agriculture Index

Loading

Please wait while we load your information from QuoteMedia.